P
Protibea focuses on developing novel therapeutics for neuroinflammatory disorders characterized by immune dysregulation. The company targets underlying immunological pathways to address the root causes of these complex neurological conditions. Their work aims to provide new treatment options for patients suffering from these debilitating diseases.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Protibea focuses on developing novel therapeutics for neuroinflammatory disorders characterized by immune dysregulation. The company targets underlying immunological pathways to address the root causes of these complex neurological conditions. Their work aims to provide new treatment options for patients suffering from these debilitating diseases.